Clin2
NCT02732860Possibly a fitRecruiting

Test your tumor’s drug response using a lab model

Colorectal NeoplasmsColorectal CancerBreast CancerBreast NeoplasmsOvarian CancerOvarian Neoplasm

Part of Cancer, Digestive system, Hormones & metabolism, Skin, Women’s health & pregnancy clinical trials.

This trial grows a lab model from your own tumor tissue (or resected tissue) to predict which drugs might work best. It’s meant to match investigational treatments to your specific tumor biology.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be over 18 years old
  • You have one of these cancers: triple-negative breast cancer, stage IV colorectal cancer, advanced high-grade serous ovarian cancer, or another solid tumor the study team selects
  • Your cancer must be accessible for a biopsy or surgery so enough tissue can be collected
  • Your overall health/activity level must be good (ECOG 0–1)
  • You must be able to give informed consent (and not have a condition like severe dementia that prevents this)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02906943Recruiting
Testing cancer tissue to guide targeted treatment choices

This trial studies advanced solid tumors by using stored tumor samples to look for molecular clues. The goal is to help doctors better choose cancer treatments that may work for your specific tumor.

Hamilton, Ontario
NCT06702800Recruiting
Using tumor models to predict breast cancer drug response

This study uses a personal lab-grown model of your tumor (called an organoid) to help predict which drugs are most likely to work for your specific breast cancer. It is open to both early-stage and advanced breast cancer patients who are about to start or are already receiving treatment.

Changsha, Hunan
NCT06077591Recruiting
Genetic and organoid testing to guide cancer treatment

This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.

Hong Kong, N.T.
NCT07516626Not yet recruiting
Using Your Tumor to Test Chemotherapy Response

This study grows mini versions of your breast cancer tumor in the lab to understand why some cancers resist chemotherapy. Researchers use this information to help predict which treatment might work best for you.

Istanbul
NCT07500259Not yet recruiting
Personalized drug testing for GI tumors

This trial uses a lab test to see how your tumor responds to different drugs, helping doctors choose the best treatment for you. It is for people with pancreatic cancer (PDAC) who are having surgery or a biopsy.

NCT06413212Recruiting
Personalized drug test for advanced cancer with fluid buildup

This trial uses a special test on your cancer cells to find which chemotherapy might work best for you. The aim is to treat advanced cancer that has caused fluid buildup in the chest or abdomen.

Wuhan, Hubei

Hear when a new Colorectal cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.